Mahaveer Biotech Private Limited
Manufactures and sells yarn and other fibrous substances, established in 2021.
2021 | Indore, Madhya Pradesh (India) | Active
Mahaveer Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 5.00 Cr
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -79.80%
- Profit Growth -97.87%
- Ebitda -95.69%
- Net Worth 2.12%
- Total Assets -24.42%
About Mahaveer Biotech
Mahaveer Biotech Private Limited (MBPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 July 2021 (Three years and seven months 17 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gomtesh Doshi and Ankita Doshi serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U17299MP2021PTC056676
- Company No.
056676
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Agriculture
Who are the key members and board of directors at Mahaveer Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gomtesh Doshi  | Director | 13-Jul-2021 | Current |
| Ankita Doshi | Director | 13-Jul-2021 | Current |
Financial Performance of Mahaveer Biotech.
Mahaveer Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 79.8% decrease. The company also saw a substantial fall in profitability, with a 97.87% decrease in profit. The company's net worth moved up by a moderate rise of 2.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mahaveer Biotech?
In 2023, Mahaveer Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Rrg Organic Farms India Llp
Gomtesh Doshi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mahaveer Biotech?
Mahaveer Biotech has a workforce of 8 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahaveer Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahaveer Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.